TPWA
AMED

Twin Peaks Wealth Advisors’s Amedisys AMED Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7
Closed -$707 – 254
2025
Q2 		$707 Buy
+7
New +$662 ﹤0.01% 1840

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Twin Peaks Wealth Advisors's AMED Position: Q3 2025 in Review

Twin Peaks Wealth Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 7 shares — an estimated $707 sold.

Twin Peaks Wealth Advisors first reported a position in AMED in Q2 2025 and held it in 1 quarter. The position peaked at $707 in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Twin Peaks Wealth Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 7 Amedisys shares in Q3 2025, an estimated $707.
  • Twin Peaks Wealth Advisors first reported a position in Amedisys in Q2 2025 and held it in 1 quarter.
  • Twin Peaks Wealth Advisors's Amedisys position peaked at $707 in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Twin Peaks Wealth Advisors's 13F filing for Q3 2025, filed 30 Oct 2025.